The effects of gestational diabetes mellitus (GDM) were determined on urinary excretion of putative components of insulin signaling. Random urine samples were collected from 375 gravidas at 6 to 14 weeks’ gestation, 22 to 32 weeks’ gestation, and ∼6 weeks’ postpartum. Gestational diabetes mellitus developed in 35 women who were matched with 59 normal gravidas. Urinary concentrations of myo-inositol (MI) and D-chiro-inositol (DCI) were measured by gas chromatography/mass spectrometry and normalized to creatinine levels. Compared to postpartum values, urinary excretion of MI and DCI was increased 2.9-fold and 2-fold, respectively, in early pregnancy, and 5.5-fold and 4.5-fold, respectively, in later gestation. Gravidas with GDM had significantly greater MI and DCI excretion than controls in the first trimester but not subsequently. The results suggest that gravidas destined to develop GDM have altered synthesis, metabolism, and/or renal excretion of MI and DCI in early pregnancy.
CatalanoPMTybirEDRomanNMAminiSBSimsEA. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol. 1991;165(6 pt 1):1667–1672.
2.
CatalanoPM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010;140(3):365–371.
3.
Kautzky-WillerABancher-TodescaD. Endocrine changes in diabetic pregnancy. In: DjelmišJIvaniševićM, eds. Diabetology of Pregnancy, Frontiers in Diabetes. Vol 17. Basel, Switzerland: Karger Medical and Scientific Publishers; 2005;18–33.
4.
YenSSCTsaiCCVelaP. Gestational diabetogenesis: quantitative analyses of glucose-insulin interrelationship between normal pregnancy and pregnancy with gestational diabetes. Am J Obstet Gynecol. 1971;111(6):792–800.
5.
BowesSBHennessyTRUmplebyAM. Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes. Diabetologia. 1996;39(8):976–983.
6.
HomkoCSivanEChenXReeceEABodenG. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab. 2001;86(2):568–573.
7.
LarnerJBrautiganDLThornerMO. D-Chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med. 2010;16(11-12):543–551.
8.
LarnerJ. D-chiro-inositol—its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res. 2002;3(1):47–60.
9.
OrtmeyerHKBodkinNHansenBCLarnerJ. In vivo D-chiroinositol activates skeletal muscle glycogen synthase and inactivates glycogen phosphorylase in rhesus monkeys. Nutr Biochem. 1995;6(9):499–503.
10.
RademacherTWCaroHKunjaraSWangDYGreenbaumALMcLeanP. Inositolphosphoglycan second messengers. Braz J Med Biol Res. 1994;27(2):327–341.
11.
SaltielAR. Second messengers of insulin action. Diabetes Care. 1990;13(3):244–256.
12.
DaughadayWHLarnerJ. The renal excretion of inositol in normal and diabetic human beings. J Clin Invest. 1954;33(3):326–332.
13.
HongJHJangHWKangYE. Urinary chiro- and myo-inositol levels as a biological marker for type 2 diabetes mellitus. Dis Markers. 2012;33(4):193–199.
14.
JungTSHahmJRKimJJ. Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients. Yonsei Med J. 2005;46(4):532–538.
15.
LarnerJCraigJW. Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance. Diabetes Care. 1996;19(1):76–78.
16.
OstlundREJrMcGillJBHerskowitzIKipnisDMSantiagoJVShermanWR. D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993;90(21):9988–9992.
17.
KenningtonASHillCRCraigJ. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1990;323(6):373–378.
18.
BaillargeonJPDiamanti-KandarakisEOstlundREJrApridonidzeTIuornoMJNestlerJE. Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care. 2006;29(2):300–305.
19.
BaillargeonJPNestlerJEOstlundREApridonidzeTDiamanti-KandarakisE. Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Hum Reprod. 2008;23(6):1439–1446.
20.
StullAJThyfaultJPHaubMDOstlundRECampbellWW. Relationship between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation. Metabolism. 2008;57(11):1545–1551.
21.
CarpenterMWCoustanDR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–773.
22.
DavisonJMDunlopW. Renal hemodynamic and tubular function in normal human pregnancy. Kidney Int. 1980;18(2):152–161.
23.
DavisonJM. Overview: kidney function in pregnant women. Am J Kid Dis. 1987;9(4):248–252.
24.
LinXMaLFitzgeraldRLOstlundRE. Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells. Arch Biochem Biophys. 2009;481(2):197–201.
25.
LahjoujiKAouameurRBissonnettePCoadyMJBichetDGLapointeJY. Expression and functionality of the Na+/myo-inositol cotransporter SMIT2 in rabbit kidney. Biochem Biophys Acta. 2007;1768(5):1154–1159.
26.
LindTHyttenFE. The excretion of glucose during normal pregnancy. J Obstet Gynaecol Br Commonw. 1972;79(11):961–965.
27.
SciosciaMPesciAZamboniGHuppertzBRestaL. D-chiro-inositol phosphoglycan expression in human placenta at term in diabetes. Arch Gynecol Obstet. 2013;288(2):459–460.
28.
SciosciaMGumaaKSelvaggiLERodeckCHRademacherTW. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes. J Perinat Med. 2009;37(5):469–471
29.
SciosciaMKunjaraSGumaaK. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Gynecol Obstet Invest. 2007;64(4):217–223.
30.
AsplinIGalaskoGLarnerJ. Chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci U S A. 1993;90(13):5924–5928.
31.
KawaJMPrzybylskiRTaylorCG. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozocin diabetic rat. Exp Bio Med. 2003;228(8):907–914.
32.
SunTHeimarkDNguygenTNadlerJLarnerJ. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol and to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochem Biophys Res Commun. 2002;293(3):1092–1098.
33.
OstlundREJrShermanWR. Measurement of D-chiro-inositol in clinical studies. Diabetes Care. 1995;18(7):1074–1075.
